Fresenius SE & CO. KGAA Detailed Consensus
Consensus as of: 2023-10-27

Please note: Consensus estimates are before special items.


KPI[EUR m]Q3 2022Q1-Q3 2022FY 2022Q3 2023 E9M 2023 EFY 2023 E
Revenue ex FMENumber of Estimates10108
Revenue ex FMEHighest5,620.516,723.522,850.4
Revenue ex FMEConsensus (Mean)5,386.015,862.021,532.05,532.616,635.622,597.6
Revenue ex FMEMedian5,547.916,650.922,599.4
Revenue ex FMELowest5,392.016,495.022,398.8
Organic Revenue growth ex FME (in %)Number of Estimates444
Organic Revenue growth ex FME (in %)Highest7.07.05.8
Organic Revenue growth ex FME (in %)Consensus (Mean)5.64.74.55.46.15.6
Organic Revenue growth ex FME (in %)Median5.26.15.6
Organic Revenue growth ex FME (in %)Lowest4.35.05.4
EBIT ex FMENumber of Estimates1097
EBIT ex FMEHighest550.01,659.02,494.9
EBIT ex FMEConsensus (Mean)480.01,631.02,190.0493.91,604.92,243.7
EBIT ex FMEMedian487.91,606.02,224.2
EBIT ex FMELowest432.41,541.42,071.1
EBIT margin (in %)Number of Estimates1097
EBIT margin (in %)Highest9.89.910.9
EBIT margin (in %)Consensus (Mean)8.910.310.28.99.69.8
EBIT margin (in %)Median8.89.69.7
EBIT margin (in %)Lowest7.79.28.8
Net interest ex FMENumber of Estimates65-
Net interest ex FMEHighest-78.3-269.3-
Net interest ex FMEConsensus (Mean)-67.0-161.0-241.0-105.4-295.9-
Net interest ex FMEMedian-107.5-298.0-
Net interest ex FMELowest-119.0-310.0-
Taxes ex FMENumber of Estimates65-
Taxes ex FMEHighest-71.0-306.0-
Taxes ex FMEConsensus (Mean)-93.0-326.0-437.0-91.3-326.5-
Taxes ex FMEMedian-91.8-328.6-
Taxes ex FMELowest-110.0-345.0-
Non-controlling interest ex FMENumber of Estimates54-
Non-controlling interest ex FMEHighest20.0-4.0-
Non-controlling interest ex FMEConsensus (Mean)-24.0-72.0-78.0-7.6-30.6-
Non-controlling interest ex FMEMedian-13.0-37.4-
Non-controlling interest ex FMELowest-19.3-43.3-
Group net income ex FMENumber of Estimates87-
Group net income ex FMEHighest331.3990.3-
Group net income ex FMEConsensus (Mean)296.01,072.01,434.0290.6953.3-
Group net income ex FMEMedian302.8962.9-
Group net income ex FMELowest215.0874.0-
EPS (in EUR)Number of Estimates87-
EPS (in EUR)Highest0.662.02-
EPS (in EUR)Consensus (Mean)0.662.293.080.541.91-
EPS (in EUR)Median0.541.90-
EPS (in EUR)Lowest0.471.85-
Average number of ordinary shares (in million)Number of Estimates19196
Average number of ordinary shares (in million)Highest563.24563.24564.76
Average number of ordinary shares (in million)Consensus (Mean)563.24560.61561.26563.24563.24563.18
Average number of ordinary shares (in million)Median563.24563.24563.24
Average number of ordinary shares (in million)Lowest563.24563.24561.26
Fresenius Kabi, revenueNumber of Estimates10108
Fresenius Kabi, revenueHighest2,210.06,202.08,410.3
Fresenius Kabi, revenueConsensus (Mean)2,071.05,814.07,850.02,114.46,106.48,246.2
Fresenius Kabi, revenueMedian2,121.06,113.08,239.5
Fresenius Kabi, revenueLowest1,999.05,991.08,121.6
Fresenius Kabi, organic revenue growth (in %)Number of Estimates756
Fresenius Kabi, organic revenue growth (in %)Highest7.07.27.2
Fresenius Kabi, organic revenue growth (in %)Consensus (Mean)3.02.03.06.17.06.2
Fresenius Kabi, organic revenue growth (in %)Median6.57.26.5
Fresenius Kabi, organic revenue growth (in %)Lowest4.86.64.2
thereof Medtech, revenueNumber of Estimates667
thereof Medtech, revenueHighest391.91,134.91,558.4
thereof Medtech, revenueConsensus (Mean)368.01,055.01,442.0375.31,118.31,521.9
thereof Medtech, revenueMedian370.61,113.61,520.1
thereof Medtech, revenueLowest367.01,110.01,485.3
thereof Nutrition, revenueNumber of Estimates667
thereof Nutrition, revenueHighest683.21,899.22,588.8
thereof Nutrition, revenueConsensus (Mean)644.01,808.02,374.0639.31,855.32,472.6
thereof Nutrition, revenueMedian635.71,851.72,467.5
thereof Nutrition, revenueLowest605.01,821.02,387.6
thereof Biopharma, revenueNumber of Estimates667
thereof Biopharma, revenueHighest100.0254.0362.0
thereof Biopharma, revenueConsensus (Mean)64.0116.0188.090.4244.4329.2
thereof Biopharma, revenueMedian91.2245.2339.0
thereof Biopharma, revenueLowest80.1234.1235.0
Subtotal Growth Vectors, revenueNumber of Estimates667
Subtotal Growth Vectors, revenueHighest1,156.53,269.54,369.7
Subtotal Growth Vectors, revenueConsensus (Mean)1,075.02,978.04,005.01,105.03,218.04,323.7
Subtotal Growth Vectors, revenueMedian1,104.13,217.14,309.0
Subtotal Growth Vectors, revenueLowest1,054.03,167.04,283.0
Pharma (IV Drugs & Fluids), revenueNumber of Estimates667
Pharma (IV Drugs & Fluids), revenueHighest1,037.42,929.43,957.2
Pharma (IV Drugs & Fluids), revenueConsensus (Mean)995.02,835.03,845.0939.92,831.93,762.4
Pharma (IV Drugs & Fluids), revenueMedian971.02,863.03,874.3
Pharma (IV Drugs & Fluids), revenueLowest745.02,637.02,926.0
Fresenius Kabi, EBITNumber of Estimates10108
Fresenius Kabi, EBITHighest313.0887.01,180.6
Fresenius Kabi, EBITConsensus (Mean)280.0844.01,080.0291.2865.21,145.6
Fresenius Kabi, EBITMedian290.0864.01,145.5
Fresenius Kabi, EBITLowest275.1849.11,092.1
Fresenius Kabi, EBIT marginNumber of Estimates10108
Fresenius Kabi, EBIT marginHighest14.214.314.3
Fresenius Kabi, EBIT marginConsensus (Mean)13.514.513.813.814.213.9
Fresenius Kabi, EBIT marginMedian13.914.213.9
Fresenius Kabi, EBIT marginLowest12.913.913.2
thereof Growth Vectors, EBITNumber of Estimates445
thereof Growth Vectors, EBITHighest99.5283.5381.2
thereof Growth Vectors, EBITConsensus (Mean)86.0279.0339.092.9276.9372.8
thereof Growth Vectors, EBITMedian92.8276.8372.2
thereof Growth Vectors, EBITLowest86.7270.7367.8
thereof Growth Vectors, EBIT margin (in %)Number of Estimates445
thereof Growth Vectors, EBIT margin (in %)Highest9.08.88.8
thereof Growth Vectors, EBIT margin (in %)Consensus (Mean)8.09.48.58.38.68.6
thereof Growth Vectors, EBIT margin (in %)Median8.48.68.6
thereof Growth Vectors, EBIT margin (in %)Lowest7.58.38.4
thereof Pharma (IV Drugs & Fluids), EBIT Number of Estimates445
thereof Pharma (IV Drugs & Fluids), EBIT Highest209.3612.3828.2
thereof Pharma (IV Drugs & Fluids), EBIT Consensus (Mean)197.0580.0769.0199.4602.4801.4
thereof Pharma (IV Drugs & Fluids), EBIT Median197.7600.7801.6
thereof Pharma (IV Drugs & Fluids), EBIT Lowest192.9595.9781.9
thereof Pharma (IV Drugs & Fluids), EBIT margin (in %)Number of Estimates445
thereof Pharma (IV Drugs & Fluids), EBIT margin (in %)Highest21.021.221.1
thereof Pharma (IV Drugs & Fluids), EBIT margin (in %)Consensus (Mean)19.820.520.020.421.020.5
thereof Pharma (IV Drugs & Fluids), EBIT margin (in %)Median20.721.120.4
thereof Pharma (IV Drugs & Fluids), EBIT margin (in %)Lowest19.120.520.3
thereof Corporate, EBITNumber of Estimates445
thereof Corporate, EBITHighest-2.0-15.0-25.0
thereof Corporate, EBITConsensus (Mean)-2.0-14.0-28.0-7.8-20.8-28.4
thereof Corporate, EBITMedian-8.8-21.8-28.0
thereof Corporate, EBITLowest-11.5-24.5-33.0
Fresenius Helios, revenueNumber of Estimates10108
Fresenius Helios, revenueHighest2,980.09,159.012,549.6
Fresenius Helios, revenueConsensus (Mean)2,829.08,685.011,716.02,958.79,137.712,378.8
Fresenius Helios, revenueMedian2,961.49,140.412,346.0
Fresenius Helios, revenueLowest2,913.09,092.012,316.6
Fresenius Helios, organic revenue growth (in %)Number of Estimates756
Fresenius Helios, organic revenue growth (in %)Highest5.35.76.1
Fresenius Helios, organic revenue growth (in %)Consensus (Mean)6.06.36.04.75.65.5
Fresenius Helios, organic revenue growth (in %)Median4.75.65.6
Fresenius Helios, organic revenue growth (in %)Lowest4.35.44.3
Helios Germany, revenueNumber of Estimates777
Helios Germany, revenueHighest1,808.45,459.47,616.5
Helios Germany, revenueConsensus (Mean)1,731.05,272.07,021.01,799.65,450.67,333.0
Helios Germany, revenueMedian1,800.25,451.27,287.7
Helios Germany, revenueLowest1,782.95,433.97,235.4
Helios Spain, revenueNumber of Estimates777
Helios Spain, revenueHighest1,110.03,503.04,813.9
Helios Spain, revenueConsensus (Mean)1,037.03,227.04,441.01,086.63,479.64,766.2
Helios Spain, revenueMedian1,094.03,487.04,767.9
Helios Spain, revenueLowest1,045.03,438.04,663.1
Helios Fertility, revenueNumber of Estimates777
Helios Fertility, revenueHighest74.4208.4345.1
Helios Fertility, revenueConsensus (Mean)62.0184.0250.068.6202.6286.8
Helios Fertility, revenueMedian68.1202.1277.9
Helios Fertility, revenueLowest63.6197.6266.2
Fresenius Helios, EBITNumber of Estimates10108
Fresenius Helios, EBITHighest265.7887.71,456.7
Fresenius Helios, EBITConsensus (Mean)222.0831.01,185.0243.4865.41,269.0
Fresenius Helios, EBITMedian241.0863.01,243.0
Fresenius Helios, EBITLowest225.0847.01,212.0
Fresenius Helios, EBIT margin (in %)Number of Estimates10108
Fresenius Helios, EBIT margin (in %)Highest9.09.711.6
Fresenius Helios, EBIT margin (in %)Consensus (Mean)7.89.610.18.29.510.2
Fresenius Helios, EBIT margin (in %)Median8.19.410.1
Fresenius Helios, EBIT margin (in %)Lowest7.79.39.8
Helios Germany, EBITNumber of Estimates777
Helios Germany, EBITHighest153.4462.4863.6
Helios Germany, EBITConsensus (Mean)141.0449.0623.0148.0457.0674.8
Helios Germany, EBITMedian147.6456.6644.4
Helios Germany, EBITLowest144.0453.0635.6
Helios Spain, EBITNumber of Estimates777
Helios Spain, EBITHighest116.0427.0611.4
Helios Spain, EBITConsensus (Mean)83.0384.0556.093.6404.6588.3
Helios Spain, EBITMedian86.9397.9585.4
Helios Spain, EBITLowest80.0391.0572.4
Helios Fertility, EBITNumber of Estimates777
Helios Fertility, EBITHighest6.417.427.5
Helios Fertility, EBITConsensus (Mean)4.015.021.05.216.223.7
Helios Fertility, EBITMedian5.016.023.1
Helios Fertility, EBITLowest4.415.421.5
Helios Corporate, EBITNumber of Estimates777
Helios Corporate, EBITHighest0.0-9.0-9.0
Helios Corporate, EBITConsensus (Mean)-6.0-17.0-15.0-4.9-13.9-13.0
Helios Corporate, EBITMedian-5.0-14.0-13.0
Helios Corporate, EBITLowest-16.0-25.0-19.0
Fresenius Medical Care, revenueNumber of Estimates997
Fresenius Medical Care, revenueHighest5,299.814,828.820,085.2
Fresenius Medical Care, revenueConsensus (Mean)5,096.014,401.019,398.04,950.314,479.319,553.5
Fresenius Medical Care, revenueMedian4,979.814,508.819,465.2
Fresenius Medical Care, revenueLowest4,635.014,164.019,292.3
Fresenius Medical Care, revenue cc growth (in %)Number of Estimates545
Fresenius Medical Care, revenue cc growth (in %)Highest4.74.24.4
Fresenius Medical Care, revenue cc growth (in %)Consensus (Mean)3.02.32.03.43.93.4
Fresenius Medical Care, revenue cc growth (in %)Median3.13.83.5
Fresenius Medical Care, revenue cc growth (in %)Lowest2.53.72.6
Fresenius Medical Care, EBITNumber of Estimates997
Fresenius Medical Care, EBITHighest441.01,196.01,571.8
Fresenius Medical Care, EBITConsensus (Mean)470.01,322.01,817.0381.51,136.51,474.9
Fresenius Medical Care, EBITMedian380.61,135.61,483.1
Fresenius Medical Care, EBITLowest301.61,056.61,296.8
Fresenius Medical Care, EBIT margin (in %)Number of Estimates997
Fresenius Medical Care, EBIT margin (in %)Highest8.78.28.0
Fresenius Medical Care, EBIT margin (in %)Consensus (Mean)9.29.29.47.77.87.5
Fresenius Medical Care, EBIT margin (in %)Median7.67.87.6
Fresenius Medical Care, EBIT margin (in %)Lowest6.37.46.7
Fresenius Vamed, revenueNumber of Estimates10108
Fresenius Vamed, revenueHighest600.01,714.02,524.1
Fresenius Vamed, revenueConsensus (Mean)572.01,647.02,359.0574.71,688.72,450.9
Fresenius Vamed, revenueMedian572.01,686.02,441.7
Fresenius Vamed, revenueLowest545.01,659.02,392.1
Fresenius Vamed, organic revenue growth (in %)Number of Estimates756
Fresenius Vamed, organic revenue growth (in %)Highest4.93.47.0
Fresenius Vamed, organic revenue growth (in %)Consensus (Mean)10.06.02.01.52.53.6
Fresenius Vamed, organic revenue growth (in %)Median1.02.32.7
Fresenius Vamed, organic revenue growth (in %)Lowest-2.52.01.3
Fresenius Vamed, EBITNumber of Estimates10108
Fresenius Vamed, EBITHighest0.0-47.096.1
Fresenius Vamed, EBITConsensus (Mean)10.029.020.0-7.0-54.0-31.0
Fresenius Vamed, EBITMedian-6.5-53.5-44.1
Fresenius Vamed, EBITLowest-16.0-63.0-70.1
Fresenius Vamed, EBIT margin (in %)Number of Estimates10108
Fresenius Vamed, EBIT margin (in %)Highest0.0-2.83.8
Fresenius Vamed, EBIT margin (in %)Consensus (Mean)1.71.80.8-1.2-3.2-1.3
Fresenius Vamed, EBIT margin (in %)Median-1.1-3.2-1.8
Fresenius Vamed, EBIT margin (in %)Lowest-2.9-3.8-2.9
Corporate/Other, revenueNumber of Estimates10108
Corporate/Other, revenueHighest-90.0-320.0-460.0
Corporate/Other, revenueConsensus (Mean)-109.0-350.0-483.0-112.7-342.7-484.2
Corporate/Other, revenueMedian-110.4-340.4-482.3
Corporate/Other, revenueLowest-135.0-365.0-507.2
Corporate/Other, EBITNumber of Estimates10108
Corporate/Other, EBITHighest-20.0-60.0-80.0
Corporate/Other, EBITConsensus (Mean)-33.0-74.0-98.0-35.8-75.8-141.4
Corporate/Other, EBITMedian-22.5-62.5-131.0
Corporate/Other, EBITLowest-120.0-160.0-280.0
Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.